Conexeu Sciences Inc.
NASDAQ:CNXU · NASDAQ Capital Market
-$0.42 today
Vol 0.04M · Avg 0.09M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Brian K. Pilcher | Chief Medical Officer | $127,500.00 | — | 57 | — | — |
David R. Bogart | Founder & Director | $110,000.00 | — | 56 | — | — |
Claudia Chavez-Munoz | Founder & Chief Scientific Officer | $100,000.00 | — | 46 | — | — |
Stephen D. Inouye | CFO, Corporate Secretary & Treasurer | $47,200.00 | — | 65 | — | — |
Miles D. Harrison | President, CEO & Director | $23,723.00 | — | 61 | — | — |
Falconne | Head of Business Development & Licensing | — | — | — | — | — |
Sonia Thomas | Head of Strategy & Transformation | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Peer companies in the same sector
No competitor data available.
Who manages CNXU?
Conexeu Sciences Inc. (CNXU) lists 7 active executives. The top listed executive is Brian K. Pilcher, Chief Medical Officer.
Are CNXU insiders buying or selling?
Recent insider activity shows net buying of $0.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.